clarity please

Having followed BNO for many years and been an accumulating investor over the last 18 months, I do have one question I'm unsure of. The BCN210 PTSD Trail Phase II is underway and we can expect top line results Q3/4, OK understood, however there is the (larger market potential) Generalised Anxiety/Panic Disorder Phase 2 trial running simultaneously. This Phase II Trial started some time back yet I'm not sure (even roughly) when we can expect top line results. A lot of focus on PTSD Trial but the big money maker all a bit quiet. Also is it a far bigger study that PTSD Trial , a longer Trial evaluation period etc? Or is this Trial Data also Q3/4? Thats basically where it comes up red or black on the roulette wheel and we're flying high or walking away. If anyone can enlighten me I'd appreciate it.